CBL anticorps (AA 863-877)
Aperçu rapide pour CBL anticorps (AA 863-877) (ABIN2617754)
Antigène
Voir toutes CBL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 863-877
-
Réactivité croisée (Details)
- No cross reactivity with other proteins.
-
Purification
- Immunogen affinity purified
-
Immunogène
- A synthetic peptide corresponding to a sequence at the C-terminus of human CBL(863-877aa NLMSQGYSYQDIQKA), identical to the related rat and mouse sequences.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- Distilled water
-
Concentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
-
Autre désignation
- C-CBL
-
Sujet
-
Name/Gene ID: CBL
Synonyms: CBL, C-CBL, Oncogene CBL2, RING finger protein 55, Proto-oncogene c-Cbl, RNF55, CBL2, FRA11B, NSLL -
ID gène
- 867
-
Pathways
- TCR Signaling, Interferon-gamma Pathway, EGFR Signaling Pathway, EGFR Downregulation, VEGFR1 Specific Signals
Antigène
-